Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IGHG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLA2G6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NARFL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WRAP73 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SQSTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAPPC9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUEDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SREBF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BAG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NINJ1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGFLR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507520 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BICDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAAP100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BANP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf60 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
YIPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on